![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 1
2022
Torlot, Lucien; Jarzab, Anna; Albert, Johanna; Pok-Udvari, Agnes; Stahler, Arndt; Holch, Julian Walter; Gerlinger, Marco; Heinemann, Volker; Klauschen, Frederick; Kirchner, Thomas; Kumbrink, Jörg; Küster, Bernhard und Jung, Andreas 
ORCID: https://orcid.org/0000-0001-5270-9108
(2022):
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-5270-9108
(2022):
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682
[PDF, 2MB]